European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
Comparison between intralesional steroid injection vs. blue laser therapy for Reinke's edema in an office setting: a case study.
СтатьяСравнительное исследованиеНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hamdan Abdul-Latif, Ghzayel Lana, Semaan Zeina Maria, Abou Chaar Jonathan, Aboul Hosn Omar, Carapiperis Ibana, Abou Raji Feghali Patrick
Аннотация
PURPOSE: The purpose of this study is to compare office-based laser therapy (OBLT) to intralesional steroid injections (ILSI) in the treatment of Reinke's edema (RE).
METHODS: The medical records and video-recordings of patients diagnosed with RE who underwent office-based therapy at the Voice and Swallowing Unit between November 2022 and December 2024 were reviewed. The primary outcome measures used were disease regression and patient-reported improvement in voice quality. Secondary outcome measures included acoustic voice parameters.
RESULTS: A total of 19 patients were included in the study, with a mean age of 55 ± 13.28 years. Two patients had unilateral disease while 17 had bilateral disease (total of 36 lesions). Seventeen lesions were rated as type 1, two as type 2 and fourteen as type 3. Partial disease regression was noted in 24 lesions (66.7%) and complete disease regression was noted in 12 lesions (33.3%). There was no statistically significant difference in partial or complete disease regression between OBLT and ILSI (p = 0.414 and p = 0.248, respectively). There was no statistically significant difference in the drop of mean VHI-10 scores between the two groups (p = 0.252). There was also no significant difference in the change in any of the acoustic parameters.
CONCLUSION: OBLT and ILSI are effective in treating RE. There was no significant difference in any of the outcome measures between the two approaches. A larger sample size is needed to establish if there are disease-related differences, such as type of RE using either treatment modality.
METHODS: The medical records and video-recordings of patients diagnosed with RE who underwent office-based therapy at the Voice and Swallowing Unit between November 2022 and December 2024 were reviewed. The primary outcome measures used were disease regression and patient-reported improvement in voice quality. Secondary outcome measures included acoustic voice parameters.
RESULTS: A total of 19 patients were included in the study, with a mean age of 55 ± 13.28 years. Two patients had unilateral disease while 17 had bilateral disease (total of 36 lesions). Seventeen lesions were rated as type 1, two as type 2 and fourteen as type 3. Partial disease regression was noted in 24 lesions (66.7%) and complete disease regression was noted in 12 lesions (33.3%). There was no statistically significant difference in partial or complete disease regression between OBLT and ILSI (p = 0.414 and p = 0.248, respectively). There was no statistically significant difference in the drop of mean VHI-10 scores between the two groups (p = 0.252). There was also no significant difference in the change in any of the acoustic parameters.
CONCLUSION: OBLT and ILSI are effective in treating RE. There was no significant difference in any of the outcome measures between the two approaches. A larger sample size is needed to establish if there are disease-related differences, such as type of RE using either treatment modality.